Zachery Carter
HomeProductsFAQSign In
© 2026 Zachery Carter. All rights reserved.
ProductsFAQadmin@mypeptide.net(850) 384-0430Sign In
Legal
MyPeptide Privacy PolicyShipping and Returns PolicyMyPeptide Terms and Conditions
FDA DISCLAIMER

Statements made regarding our products have not been evaluated by the U.S. Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. Products are not intended to diagnose, treat, cure, or prevent any disease. Information presented on this website is not a substitute for, or alternative to, information from a qualified health care practitioner. Please consult a licensed health care professional regarding any potential interactions or complications before using any product. This notice is required under the Federal Food, Drug, and Cosmetic Act.

HomeShopSign In

Researcher verification

MyPeptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

© 2026 MyPeptide.net all rights reserved
Back to catalog
Fox-04 (10mg)
Longevity & Neuro Research
Research Use Only — Not for Human or Veterinarian Administration

Fox-04 (10mg)

FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction in senescent cells, investigated as a senolytic agent in aging and cellular senescence research.

Select size

lyophilized
$99.00/ Fox-04 (10mg)
Certificate of Analysis — Fox-04 (10mg)Certificate of AnalysisThird-party HPLC lab report · opens PDF

For laboratory and research use only. Not for human or veterinary use.

Mechanism of Action

The D-retro-inverso modification confers protease resistance. The peptide competitively interferes with FOXO4-p53 binding, selectively inducing apoptosis in senescent cells while sparing proliferating cells in preclinical models.

Research Applications

  • Cellular senescence and senolytic assays
  • FOXO4-p53 interaction studies
  • Aging and tissue rejuvenation research models

Specifications

sequenceD-retro-inverso FOXO4-p53 interfering peptide
molecular Weight~5350 Da
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water. Handle as a sensitive research peptide.

Storage & Handling

Lyophilized: −20 °C recommended for long-term. Reconstituted: refrigerate; use promptly.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Baar MP, et al. Targeted apoptosis of senescent cells restores tissue homeostasis. Cell. 2017. · PubMed →
  2. 2.Childs BG, et al. Cellular senescence in aging and disease. Science. 2017. · PubMed →